Sign in
CompletedNo phase

The Effect of CUGP Fluid Management in Patients With Sepsis or Septic Shock

Key facts

Who runs it
Shusheng Li
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
118 people enrolled
Started
1 Apr 2025
Ended
28 Jan 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • critical ultrasonography
Record updated
30 January 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • 1. Age ≥ 18 years old
  • 2. Estimated length of ICU stay ≥ 24 hours
  • 3. Diagnosis according to the Sepsis 3.0 criteria, which included:
  • a. suspected or confirmed infections supported by clinical evidence and/or positive microbiological findings
  • b. the sepsis related organ failure assessment (SOFA) score ≥ 2

Who cannot take part

  • 8. Patients had drug poisoning
  • 2. Patients had acute coronary syndrome
  • 5. Patients had malignant arrhythmia
  • 6. Patients had active gastrointestinal bleeding
  • 7. Patients had epileptic seizure
  • 11. Patients had intra-abdominal hypertension (intra-abdominal pressure increases continuously ≥ 12mmHg)
  • 14. Patients had cardiac structural or functional abnormalities (left ventricular outflow tract obstruction, moderate-to-severe mitral regurgitation, aortic regurgitation), it would seriously affect the velocity time integral of left ventricular outflow tract
  • 1. Patients were pregnant woman
  • 3. Patients had acute pulmonary edema
  • 4. Patients had status asthmatics
  • 9. Patients had severe burns
  • 10. Patients had contraindications of blood transfusion
  • 12. Patients had acute pulmonary embolism
  • 13. Patients had contraindications of leg raising
  • 15. Patients or their legal representatives refused active treatment
  • 16. Patients or their legal representatives refused to participate in this study
  • 17. Patients were participating in other interventional clinical trials

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to assess whether procedural critical ultrasonography guided precise fluid management (CUGP) can affect the clinical fluid management strategy and improve the outcomes of patients with sepsis or septic shock.

The 2 groups in the trial

  • CUGP groupTreatment being tested

    In the CUGP group, ultrasonographic assessment was performed by a team of trained critical ultrasonography physicians at enrollment, 1 hour, 3 hours, 6 hours, 12 hours, 24 hours, 48 hours, and 72 hours thereafter, respectively.

    Treatment: critical ultrasonography

  • usual care groupNo study treatment, for comparison

    The usual care group used conventional hemodynamic monitoring methods for monitoring and decision-making about fluid management. Records were made at enrollment, 1 hour, 3 hours, 6 hours, 12 hours, 24 hours, 48 hours, and 72 hours thereafter, respectively.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Critical Ultrasonography Guided Precise Fluid Management in Patients With Sepsis or Septic Shock: A Single-center Randomized Controlled Trial
Record updated
30 January 2026